Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Rev Med Interne ; 27(12): 924-6, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17011081

ABSTRACT

BACKGROUND: Intravenous (IV) and subcutaneous (SC) immunoglobulin (Ig) administration is a safe and an efficacious treatment in patients with IgG deficiency. Home administration of IV Ig and SC Ig has recently been approved in France. Most of the patients treated in hospital ask for home treatment. Some patients prefer monthly IV administration, others weekly SC administration. MATERIAL AND METHODS: We evaluated in details the cost of both of these practices. We currently use electric pumps for both IV and SC administration which are fixed to the patient giving complete freedom and mobility. RESULTS: For 20 g administrated per 4 week, the total cost of home treatment is 1,518 euro with SC Ig and 1,033 euro with IV Ig. For 40 g administrated per 4 week, the total cost of home treatment is 2,507 euro to 2,729 euro with SC Ig and 2,034 euro with IV Ig. The difference is mainly explained by the cost of renting the electric pumps and by the cost of furniture for SC administration. The choice of home Ig substitution must be given to all patient receiving treatment in hospital. CONCLUSIONS: Home IV and home SC perfusions are two possible options each different with there own advantages and disadvantages. The cost of each procedure must be known by the medical staff.


Subject(s)
Home Care Services/economics , Immunoglobulins, Intravenous/economics , Immunoglobulins/administration & dosage , Immunoglobulins/economics , Immunologic Deficiency Syndromes/drug therapy , Immunologic Deficiency Syndromes/economics , Cost-Benefit Analysis , France , Humans , Injections, Subcutaneous/economics
2.
Ann Pharm Fr ; 58(3): 165-9, 2000 May.
Article in French | MEDLINE | ID: mdl-10844276

ABSTRACT

Aerosols of methacholine chloride are used in inhalation tests to measure non-specific bronchial responsiveness. Inhalation challenge solutions are not commercially available neither by pharmaceutical industry nor in France by the PCH-APHP. To reply to doctor's request, dilute concentrations of methacholine must be prepared properly in order to protect the patient and to assure doctor of test reproductibility. Osmolarity, pH and degradation of different dilute concentration of methacholine chloride have been compared with two diluents. This study allowed us to validate our preparation of solutions.


Subject(s)
Bronchial Hyperreactivity/chemically induced , Bronchial Provocation Tests , Bronchoconstrictor Agents , Methacholine Chloride , Administration, Inhalation , Bronchial Hyperreactivity/pathology , Bronchoconstrictor Agents/administration & dosage , Bronchoconstrictor Agents/chemistry , Drug Compounding , Methacholine Chloride/administration & dosage , Methacholine Chloride/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL